Has Nolan Kinne, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,985 in general payments to Nolan Kinne, MD across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nolan Kinne, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nolan Kinne, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nolan Kinne, MD

Obstetrics & Gynecology · Los Angeles, CANPI 1811495914

Payments from drug & device makers

$3,985in general payments, 2019–2025

Across 18 payments — averaging $221.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$3K
AbbVie$183
AstraZeneca$168
Verastem, Inc.$153
Merck$115
GSK$100
plus $16 from 1 others

What the payments were for

Speaking & faculty fees$2,10053%
Travel & lodging$82621%
Food & beverage$1,05927%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	8	$3,250
AbbVie	3	$183
AstraZeneca	2	$168
Verastem, Inc.	1	$153
Merck	1	$115
GSK	2	$100
Monaghan Medical Corporation	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,985 in reported general payments places this provider in the 85th percentile of 3,784 obstetrics & gynecology providers in California.

See all obstetrics & gynecology providers in California →

Medicare billing

Part B allowed, 2024

$29,338

Medicare patients

Services billed

178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	21	$9,521
Ondansetron OdtOndansetron	14	$444
Ondansetron Hcl	25	$439
Sodium Chloride0.9 % Sodium Chloride	16	$316
Prochlorperazine Maleate	24	$297
Dexamethasone	46	$217
Methocarbamol	16	$90
Gabapentin	14	$90
Ibuprofen	11	$63

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Los Angeles

Oleg BessLos Angeles$1.7M
Michael FassettLos Angeles$1.2M
Ritu SalaniLos Angeles$741K
Malcolm MunroLos Angeles$609K
Ramon YeraLos Angeles$296K
Aela PaizLos Angeles$131K
Radhika RibleLos Angeles$116K
Carolyn HaunschildLos Angeles$97K
Peyman BanooniBeverly Hills$9.2M
Vellore BhupathyWhittier$4.3M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →